Detection and measurement of microparticles: An evolving research tool for vascular biology

被引:89
作者
Enjeti, Anoop K. [1 ]
Lincz, Lisa F. [1 ]
Seldon, Michael [1 ]
机构
[1] Calvary Mater Hosp, Hunter Haematol Res Grp, Dept Haematol, Waratah Newcastle, Australia
关键词
microparticles; detection; measurement; research tool; vascular biology;
D O I
10.1055/s-2007-1000369
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Microparticles are small, membrane-bound vesicles that are generated from cells of different origin. It now appears that all circulating blood cells as well as endothelial cells release membranous fragments similar to 1 mu m in size or smaller bearing at least some characteristics of the parent cell. Elevated levels of microparticles have been described in cardiovascular states, thrombotic conditions, and cancer. Various methods of detection for microparticles include flow cytometry, enzyme-linked immunoassays, and functional assays. Flow cytometry has several advantages including its ability to quantitate and identify microparticles of different cellular origin. However, the standardization of preanalytical and analytical variables for enumeration of microparticles remains a significant challenge. Newer approaches are being investigated, and an international collaboration is working on standardization of detection as well as quantitation of microparticles by flow cytometry. Although it has evolved as an important vascular biology research tool, microparticle detection needs further evaluation and refinement before it becomes truly useful as a clinical tool.
引用
收藏
页码:771 / 779
页数:9
相关论文
共 69 条
  • [61] Imaging and analysis of immobilized particle arrays
    Stevens, PW
    Kelso, DM
    [J]. ANALYTICAL CHEMISTRY, 2003, 75 (05) : 1147 - 1154
  • [62] Pro- and non-coagulant forms of non-cell-bound tissue factor in vivo
    Sturk-Maquelin, KN
    Nieuwland, R
    Romijn, FPHTM
    Eijsman, L
    Hack, CE
    Sturk, A
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (09) : 1920 - 1926
  • [63] Tamilvanan S, 2006, AAPS PHARMSCITECH, V7
  • [64] Tedgui A, 2001, THROMB HAEMOSTASIS, V86, P420
  • [65] Flow cytometry detection of platelet procoagulant activity and microparticles in patients with unstable angina treated by percutaneous coronary angioplasty and stent implantation
    Vidal, C
    Spaulding, C
    Picard, F
    Schaison, F
    Melle, J
    Weber, S
    Fontenay-Roupie, M
    [J]. THROMBOSIS AND HAEMOSTASIS, 2001, 86 (03) : 784 - 790
  • [66] Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes
    Villmow, T
    Kemkes-Matthes, B
    Matzdorff, AC
    [J]. THROMBOSIS RESEARCH, 2002, 108 (2-3) : 139 - 145
  • [67] SYNTHETIC DELIVERY SYSTEM FOR TUBERCULOSIS VACCINES - IMMUNOLOGICAL EVALUATION OF THE MYCOBACTERIUM-TUBERCULOSIS 38 KDA PROTEIN ENTRAPPED IN BIODEGRADABLE PLG MICROPARTICLES
    VORDERMEIER, HM
    COOMBES, AGA
    JENKINS, P
    MCGEE, JP
    OHAGAN, DT
    DAVIS, SS
    SINGH, M
    [J]. VACCINE, 1995, 13 (16) : 1576 - 1582
  • [68] Warkentin TE, 1999, PLATELETS, V10, P319
  • [69] WHITE JG, 1980, AM J PATHOL, V101, P613